Integrated analysis of cellular responses to toxins from clostridium difficile

细胞对艰难梭菌毒素反应的综合分析

基本信息

  • 批准号:
    8233381
  • 负责人:
  • 金额:
    $ 32.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

C. difficile colitis is a toxin-mediated disease, which is dependent on the actions of Toxin A (TcdA) and/or Toxin B (TcdB). Although the molecular mechanisms by which TcdA and TcdB modify Rho-subfamily GTPases are well defined, the pathways connecting those events to colitis and inflammatory diarrhea remain elusive. In this sub-project of MARCE Research Program V (Interactions of Select Agent Toxins and Toxins of Emerging Bacterial Pathogens with Host Cells), we will combine the analytical methods of systems biology with expression profiles (gene expression and protein modification) and associated biological consequences, in order to elucidate the pathways affected by the specific toxin-mediated glucosylation of one or more small GTPases. Cultured human cells alone and in combinations (intestinal epithelium and other cell types directly affected by the toxins) will be studied in vitro and mouse ligated ileal loops will be studied in vivo to characterize the phenotypes induced by the toxins and to determine the optimal conditions for collection of the gene array data. A novel pathway-based compendium analysis will be used to overlay the in vitro and in vivo transcriptional profiles on a literature-derived pathway knowledge database, thereby identifying signaling networks altered by the toxins (SA 1). Concurrently, data derived through gene expression arrays will be validated using qRT-PCR, Western blotting, phospho-protein analyses and in situ hybridization. Partial least-squares regression analysis will be applied to the collective data, in order to characterize the key signaling metrics for the phenotypes elicited by TcdA and TcdB (SA 2). New hypotheses will then be generated and tested by making biological and biochemical manipulations of the newly recognized pathways and signaling molecules and determining the biological consequences with and without the toxins (SA 3). This exciting project reflects a close interaction of three groups, representing: 1) microbial toxin action and molecular pathogenesis (Hewlett); 2) pathogenesis of diseases caused by enteric pathogens and enterotoxins (Guerrant and Warren) and 3) systems bioengineering in infectious diseases (Papin).
C.艰难梭菌结肠炎是一种毒素介导的疾病,其依赖于毒素A(TcdA)的作用。 和/或毒素B(TcdB)。虽然TcdA和TcdB修饰Rho亚家族的分子机制 GTP酶定义明确,将这些事件与结肠炎和炎性腹泻联系起来的途径仍然存在 难以捉摸。在MARCE研究计划V的这个子项目中(选择代理毒素和 新出现的细菌病原体与宿主细胞的毒素),我们将结合联合收割机的分析方法, 系统生物学与表达谱(基因表达和蛋白质修饰)和相关 生物学后果,以阐明受特定毒素介导的 一种或多种小GTP酶的葡糖基化。单独培养的人细胞和组合培养的人细胞(肠 上皮和其他直接受毒素影响的细胞类型)进行体外研究, 环将在体内研究,以表征毒素诱导的表型,并确定 基因阵列数据收集的最佳条件。一个新的路径为基础的简编分析将 用于将体外和体内转录谱叠加在文献来源的途径知识上 数据库,从而识别被毒素改变的信号网络(SA 1)。同时,数据来源 通过基因表达阵列将使用qRT-PCR、蛋白质印迹、磷蛋白 分析和原位杂交。偏最小二乘回归分析将应用于集体 数据,以表征由TcdA和TcdB引起的表型的关键信号传导度量(SA 2)。 新的假设将产生和测试,通过生物和生物化学操作, 新认识的途径和信号分子,并确定生物学后果, 没有毒素(SA 3)。这个令人兴奋的项目反映了三个团体的密切互动,代表: 1)微生物毒素作用和分子发病机理(Hewlett); 2)由 肠道病原体和肠毒素(Guerrant和Warren)和3)传染病中的系统生物工程 疾病(Papin)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIK L HEWLETT其他文献

ERIK L HEWLETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIK L HEWLETT', 18)}}的其他基金

11th International Symposium on Bordetella
第11届博德特氏菌国际研讨会
  • 批准号:
    9053803
  • 财政年份:
    2016
  • 资助金额:
    $ 32.89万
  • 项目类别:
Bordetella cyclase toxin: effects on leukocytes and respiratory epithelial cells
博德特氏菌环化酶毒素:对白细胞和呼吸道上皮细胞的影响
  • 批准号:
    7846692
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:
Integrated analysis of cellular responses to toxins from clostridium difficile
细胞对艰难梭菌毒素反应的综合分析
  • 批准号:
    7670083
  • 财政年份:
    2009
  • 资助金额:
    $ 32.89万
  • 项目类别:
Anthrax
炭疽病
  • 批准号:
    7678783
  • 财政年份:
    2008
  • 资助金额:
    $ 32.89万
  • 项目类别:
8th International Symposium - Saga of the Genus Bordetella, 1906-2006
第八届国际研讨会 - 博德特氏菌属传奇,1906-2006
  • 批准号:
    7230901
  • 财政年份:
    2006
  • 资助金额:
    $ 32.89万
  • 项目类别:
Seventh International Symposium on Pertussis
第七届国际百日咳研讨会
  • 批准号:
    6557658
  • 财政年份:
    2002
  • 资助金额:
    $ 32.89万
  • 项目类别:
1998 GORDON CONFERENCE-MICROBIAL TOXINS & PATH
1998 年戈登会议-微生物毒素
  • 批准号:
    2670026
  • 财政年份:
    1998
  • 资助金额:
    $ 32.89万
  • 项目类别:
General Clinical Research Center
全科临床研究中心
  • 批准号:
    7591148
  • 财政年份:
    1997
  • 资助金额:
    $ 32.89万
  • 项目类别:
General Clinical Research Center
全科临床研究中心
  • 批准号:
    7821393
  • 财政年份:
    1997
  • 资助金额:
    $ 32.89万
  • 项目类别:
General Clinical Research Center
全科临床研究中心
  • 批准号:
    7229536
  • 财政年份:
    1997
  • 资助金额:
    $ 32.89万
  • 项目类别:

相似海外基金

Identification and isolation of anaerobic bacteria that degrade bacterial cell wall
降解细菌细胞壁的厌氧菌的鉴定与分离
  • 批准号:
    22H02487
  • 财政年份:
    2022
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Enzymology of cofactor and amino acid metabolism in anaerobic bacteria
厌氧菌辅助因子和氨基酸代谢的酶学
  • 批准号:
    RGPIN-2022-03200
  • 财政年份:
    2022
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Discovery Grants Program - Individual
High-throughput isolation of anaerobic bacteria
厌氧菌的高通量分离
  • 批准号:
    572711-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 32.89万
  • 项目类别:
    University Undergraduate Student Research Awards
Elucidating the mechanisms of O2-sensitivity of anaerobic bacteria Bifidobacterium.
阐明厌氧菌双歧杆菌的 O2 敏感性机制。
  • 批准号:
    22K07058
  • 财政年份:
    2022
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Automatic and accurate identification of aerobic bacteria, anaerobic bacteria, yeasts, and fungi in clinical samples derived from animals and from feed for pets
自动、准确地鉴定来自动物和宠物饲料的临床样品中的需氧细菌、厌氧细菌、酵母菌和真菌
  • 批准号:
    10440741
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Regulation of virulence in fungi under coculture condition with anaerobic bacteria
厌氧菌共培养条件下真菌毒力的调节
  • 批准号:
    21K07009
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polymicrobial interactions between commensal obligate anaerobic bacteria and cystic fibrosis pathogen P. aeruginosa
共生专性厌氧菌与囊性纤维化病原体铜绿假单胞菌之间的多种微生物相互作用
  • 批准号:
    10275319
  • 财政年份:
    2021
  • 资助金额:
    $ 32.89万
  • 项目类别:
Platform for the automated isolation and characterization of anaerobic bacteria
厌氧菌自动分离和表征平台
  • 批准号:
    445552570
  • 财政年份:
    2020
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Major Research Instrumentation
Development of therapy for triple negative breast cancer using anaerobic bacteria
利用厌氧菌开发三阴性乳腺癌疗法
  • 批准号:
    19K16452
  • 财政年份:
    2019
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of gene engineering method for anaerobic bacteria for efficient bio-hydrogen production
开发厌氧菌高效生物制氢的基因工程方法
  • 批准号:
    18K11708
  • 财政年份:
    2018
  • 资助金额:
    $ 32.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了